My Quote Request
No products added yet
6505-01-156-1600
20 Products
NDC00006-3239-66
CHLOROTHIAZIDE ORAL SUSPENSION,USP
NSN, MFG P/N
6505011561600
NSN
6505-01-156-1600
NDC00006-3239-66
CHLOROTHIAZIDE ORAL SUSPENSION,USP
NSN, MFG P/N
6505011561600
NSN
6505-01-156-1600
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CHLOROTHIAZIDE PER 5 MILLILITERS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLOROTHIAZIDE ORAL SUSPENSION USP 250MG/5ML 237ML BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 237.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
0859
CEFOPERAZONE SODIUM,USP
NSN, MFG P/N
6505011559431
NSN
6505-01-155-9431
MFG
ROERIG DIV PFIZER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2 GM. CEFOPERAZONE EQUIV. OF BASE IN VIAL
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFOPERAZONE SODIUM STERILE USP POWDER FORM 2GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO YIELD 2 GM. CEFOPERAZONE
PRIMARY CONTAINER TYPE: VIAL
TOTAL SECONDARY CONTAINER QUANTITY: 10
Related Searches:
CEFOBID
CEFOPERAZONE SODIUM,USP
NSN, MFG P/N
6505011559431
NSN
6505-01-155-9431
MFG
ROERIG DIV PFIZER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2 GM. CEFOPERAZONE EQUIV. OF BASE IN VIAL
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFOPERAZONE SODIUM STERILE USP POWDER FORM 2GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO YIELD 2 GM. CEFOPERAZONE
PRIMARY CONTAINER TYPE: VIAL
TOTAL SECONDARY CONTAINER QUANTITY: 10
Related Searches:
NDC00049-1202-83
CEFOPERAZONE SODIUM,USP
NSN, MFG P/N
6505011559431
NSN
6505-01-155-9431
NDC00049-1202-83
CEFOPERAZONE SODIUM,USP
NSN, MFG P/N
6505011559431
NSN
6505-01-155-9431
MFG
ROERIG DIV PFIZER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2 GM. CEFOPERAZONE EQUIV. OF BASE IN VIAL
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFOPERAZONE SODIUM STERILE USP POWDER FORM 2GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO YIELD 2 GM. CEFOPERAZONE
PRIMARY CONTAINER TYPE: VIAL
TOTAL SECONDARY CONTAINER QUANTITY: 10
Related Searches:
LITHONATE CAPSULES
LITHIUM CARBONATE CAPSULES,USP
NSN, MFG P/N
6505011559434
NSN
6505-01-155-9434
LITHONATE CAPSULES
LITHIUM CARBONATE CAPSULES,USP
NSN, MFG P/N
6505011559434
NSN
6505-01-155-9434
MFG
SOLVAY PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS LITHIUM CARBONATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 120.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: TAMPER PROOF
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITH 3-PART LABEL
Related Searches:
NDC00032-7512-12
LITHIUM CARBONATE CAPSULES,USP
NSN, MFG P/N
6505011559434
NSN
6505-01-155-9434
NDC00032-7512-12
LITHIUM CARBONATE CAPSULES,USP
NSN, MFG P/N
6505011559434
NSN
6505-01-155-9434
MFG
SOLVAY PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS LITHIUM CARBONATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 120.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: TAMPER PROOF
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITH 3-PART LABEL
Related Searches:
LITHONATE CAPSULES
LITHIUM CARBONATE CAPSULES,USP
NSN, MFG P/N
6505011559435
NSN
6505-01-155-9435
LITHONATE CAPSULES
LITHIUM CARBONATE CAPSULES,USP
NSN, MFG P/N
6505011559435
NSN
6505-01-155-9435
MFG
SOLVAY PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS LITHIUM CARBONATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 90.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: TAMPER PROOF
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITH 3-PART LABEL
Related Searches:
NDC00032-7512-09
LITHIUM CARBONATE CAPSULES,USP
NSN, MFG P/N
6505011559435
NSN
6505-01-155-9435
NDC00032-7512-09
LITHIUM CARBONATE CAPSULES,USP
NSN, MFG P/N
6505011559435
NSN
6505-01-155-9435
MFG
SOLVAY PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS LITHIUM CARBONATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 90.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: TAMPER PROOF
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITH 3-PART LABEL
Related Searches:
6505-00-C99-7553
DEXTROSE,POTASSIUM CHLORIDE,AND SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011559436
NSN
6505-01-155-9436
6505-00-C99-7553
DEXTROSE,POTASSIUM CHLORIDE,AND SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011559436
NSN
6505-01-155-9436
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.300 PERCENTAGE, W/V POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 0.225 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00074-5846-05
DEXTROSE,POTASSIUM CHLORIDE,AND SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011559436
NSN
6505-01-155-9436
NDC00074-5846-05
DEXTROSE,POTASSIUM CHLORIDE,AND SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011559436
NSN
6505-01-155-9436
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.300 PERCENTAGE, W/V POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 0.225 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC50111-0621-01
KETOCONAZOLE TABLETS,USP
NSN, MFG P/N
6505011560701
NSN
6505-01-156-0701
NDC50111-0621-01
KETOCONAZOLE TABLETS,USP
NSN, MFG P/N
6505011560701
NSN
6505-01-156-0701
MFG
PLIVA INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS KETOCONAZOLE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETOCONAZOLE TABLETS USP 200MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
NDC51672-4026-01
KETOCONAZOLE TABLETS,USP
NSN, MFG P/N
6505011560701
NSN
6505-01-156-0701
NDC51672-4026-01
KETOCONAZOLE TABLETS,USP
NSN, MFG P/N
6505011560701
NSN
6505-01-156-0701
MFG
TARO PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS KETOCONAZOLE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETOCONAZOLE TABLETS USP 200MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
NDC60505-0092-00
KETOCONAZOLE TABLETS,USP
NSN, MFG P/N
6505011560701
NSN
6505-01-156-0701
NDC60505-0092-00
KETOCONAZOLE TABLETS,USP
NSN, MFG P/N
6505011560701
NSN
6505-01-156-0701
MFG
APOTEX INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS KETOCONAZOLE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETOCONAZOLE TABLETS USP 200MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
15A
OPIUM,POWDERED AND BELLADONNA EXTRACT SUPPOSITORIES
NSN, MFG P/N
6505011561588
NSN
6505-01-156-1588
15A
OPIUM,POWDERED AND BELLADONNA EXTRACT SUPPOSITORIES
NSN, MFG P/N
6505011561588
NSN
6505-01-156-1588
MFG
POLYMEDICA CORPORATION
Description
ACTIVE INGREDIENT AND STRENGTH: 30.000 OPIUM, POWDERED MILLIGRAMS AND 16.200 BELLADONNA EXTRACT, POWDERED MILLIGRAMS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OPIUM POWDERED & BELLADONNA EXTRACT SUPPOSITORIES ADULT RECTAL 12S
PRIMARY CONTAINER TYPE: STRIP
SUPPOSITORY TYPE: ADULT RECTAL
UNIT PACKAGE QUANTITY: 12 SUPPOSITORIES PER PACKAGE
Related Searches:
B AND O SUPPRETTES
OPIUM,POWDERED AND BELLADONNA EXTRACT SUPPOSITORIES
NSN, MFG P/N
6505011561588
NSN
6505-01-156-1588
B AND O SUPPRETTES
OPIUM,POWDERED AND BELLADONNA EXTRACT SUPPOSITORIES
NSN, MFG P/N
6505011561588
NSN
6505-01-156-1588
MFG
POLYMEDICA CORPORATION
Description
ACTIVE INGREDIENT AND STRENGTH: 30.000 OPIUM, POWDERED MILLIGRAMS AND 16.200 BELLADONNA EXTRACT, POWDERED MILLIGRAMS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OPIUM POWDERED & BELLADONNA EXTRACT SUPPOSITORIES ADULT RECTAL 12S
PRIMARY CONTAINER TYPE: STRIP
SUPPOSITORY TYPE: ADULT RECTAL
UNIT PACKAGE QUANTITY: 12 SUPPOSITORIES PER PACKAGE
Related Searches:
NDC00574-7045-12
OPIUM,POWDERED AND BELLADONNA EXTRACT SUPPOSITORIES
NSN, MFG P/N
6505011561588
NSN
6505-01-156-1588
NDC00574-7045-12
OPIUM,POWDERED AND BELLADONNA EXTRACT SUPPOSITORIES
NSN, MFG P/N
6505011561588
NSN
6505-01-156-1588
MFG
PADDOCK LABORATORIES INC.
Description
ACTIVE INGREDIENT AND STRENGTH: 30.000 OPIUM, POWDERED MILLIGRAMS AND 16.200 BELLADONNA EXTRACT, POWDERED MILLIGRAMS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OPIUM POWDERED & BELLADONNA EXTRACT SUPPOSITORIES ADULT RECTAL 12S
PRIMARY CONTAINER TYPE: STRIP
SUPPOSITORY TYPE: ADULT RECTAL
UNIT PACKAGE QUANTITY: 12 SUPPOSITORIES PER PACKAGE
Related Searches:
NDC61451-5015-07
OPIUM,POWDERED AND BELLADONNA EXTRACT SUPPOSITORIES
NSN, MFG P/N
6505011561588
NSN
6505-01-156-1588
NDC61451-5015-07
OPIUM,POWDERED AND BELLADONNA EXTRACT SUPPOSITORIES
NSN, MFG P/N
6505011561588
NSN
6505-01-156-1588
MFG
POLYMEDICA CORPORATION
Description
ACTIVE INGREDIENT AND STRENGTH: 30.000 OPIUM, POWDERED MILLIGRAMS AND 16.200 BELLADONNA EXTRACT, POWDERED MILLIGRAMS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OPIUM POWDERED & BELLADONNA EXTRACT SUPPOSITORIES ADULT RECTAL 12S
PRIMARY CONTAINER TYPE: STRIP
SUPPOSITORY TYPE: ADULT RECTAL
UNIT PACKAGE QUANTITY: 12 SUPPOSITORIES PER PACKAGE
Related Searches:
MAXIDEX
DEXAMETHASONE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505011561595
NSN
6505-01-156-1595
MAXIDEX
DEXAMETHASONE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505011561595
NSN
6505-01-156-1595
MFG
ALCON LABORATORIES INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 PERCENTAGE, W/V DEXAMETHASONE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
SPECIAL FEATURES: MEDSEP ITEM FOR DOD,ALCON LABS INC
Related Searches:
NDC00998-0615-15
DEXAMETHASONE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505011561595
NSN
6505-01-156-1595
NDC00998-0615-15
DEXAMETHASONE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505011561595
NSN
6505-01-156-1595
MFG
ALCON LABORATORIES INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 PERCENTAGE, W/V DEXAMETHASONE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
SPECIAL FEATURES: MEDSEP ITEM FOR DOD,ALCON LABS INC
Related Searches:
DIURIL
CHLOROTHIAZIDE ORAL SUSPENSION,USP
NSN, MFG P/N
6505011561600
NSN
6505-01-156-1600
DIURIL
CHLOROTHIAZIDE ORAL SUSPENSION,USP
NSN, MFG P/N
6505011561600
NSN
6505-01-156-1600
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CHLOROTHIAZIDE PER 5 MILLILITERS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLOROTHIAZIDE ORAL SUSPENSION USP 250MG/5ML 237ML BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 237.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
